Investigators ID a new antibody that helps guard bone tissue in osteosarcoma patients

A research group at the University of Copenhagen has shown how a rare bone cancer called osteosarcoma degrades bone tissue. And they've identified an antibody which they say guarded against the bone degradation in a mouse model for the disease, possibly pointing to a new medication that could prevent the need for amputations among the young people and children suffering from this cancer. "By treating mice with OS with the new antibody, we could block the micro processes OS cells use to degrade the bones and thereby effectively protect the bone tissue," explains Lars Engelholm. Release

Suggested Articles

Researchers discovered that inactivating a subtype of the protein beta-arrestin-2 in mice restored the ability of the brain to dispose of toxic tau.

A newfound link between BMAL1, a protein involved in circadian rhythms, and triple-negative breast cancer could point to new treatment strategies.

Combining a DYRK1A inhibitor with popular GLP-1 receptor agonists regenerates insulin-producing beta cells, Mount Sinai scientists found.